Related Experiment Video
Updated: Aug 16, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Favorable response obtained by low dose chemotherapy in an elderly patient with extensive small cell lung cancer and
Katsunada Fujimoto1, Taishi Harada, Kentaro Watanabe
1Fourth Department of Internal Medicine, Division of Respiratory Medicine, Fukuoka University School of Medicine.
Abstract:
An 82-year-old man with extensive small cell lung cancer was treated with 2 courses of low dose CPT-11 (40 mg/body, day 1, 8 and 15) and carboplatin (100 mg/body, day 1). The reduction in tumor sizes evaluated by two-direction measurement was 88%. His creatinine clearance rates before and after chemotherapy were 20 and 28 ml/min, respectively. Temporary leukopenia (900/microl) during the second course of chemotherapy was quickly reversed by the administration of G-CSF, without any episode of infection. Low dose CPT-11 and carboplatin seems to be a promising regimen for elderly patients with small cell lung cancer and renal dysfunction. Cancer tends to increase in old age groups. We consider that it is necessary to examine ideal low dose chemotherapies that can be effective yet preserve quality of life.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant